Condensed Quarterly Results (Unaudited)

12 Months Ended

Mar. 30, 2014

Quarterly Financial Information Disclosure [Abstract]

Condensed Quarterly Results (Unaudited)

Note 19. Condensed Quarterly Results (Unaudited)

The following table summarizes certain unaudited quarterly financial information for fiscal 2014 and 2013:

	Three Months Ended (1)
	June (2)			September		December		March (3) (4)
	(In thousands, except per share amounts)
Fiscal 2014:
Net revenues	$	113,116		$	112,622	$	119,449	$	115,720
Gross profit		76,497			76,309		81,003		76,298
Operating income (loss)		(3,075	)		13,186		20,302		(42,633	)
Income (loss) from continuing operations		(3,050	)		10,977		20,586		(46,779	)
Net income (loss)		(3,050	)		10,977		20,586		(46,779	)
Income (loss) from continuing operations per share:
Basic	$	(0.03	)	$	0.13	$	0.24	$	(0.54	)
Diluted	$	(0.03	)	$	0.13	$	0.24	$	(0.54	)
Net income (loss) per share:
Basic	$	(0.03	)	$	0.13	$	0.24	$	(0.54	)
Diluted	$	(0.03	)	$	0.13	$	0.24	$	(0.54	)
Fiscal 2013:
Net revenues	$	130,371		$	117,867	$	119,386	$	116,914
Gross profit		87,058			78,887		80,297		79,116
Operating income		20,041			12,985		14,424		10,400
Income from continuing operations		18,441			11,780		13,705		29,635
Net income		18,386			11,874		13,241		29,635
Income from continuing operations per share:
Basic	$	0.19		$	0.13	$	0.15	$	0.33
Diluted	$	0.19		$	0.13	$	0.15	$	0.33
Net income per share:
Basic	$	0.19		$	0.13	$	0.14	$	0.33
Diluted	$	0.19		$	0.13	$	0.14	$	0.33

(1) The statement of operations data for all periods presented reflects the operating results of the IB Business as discontinued operations.

(2) During the three months ended June 30, 2013, the Company recorded special charges of $12.0 million, consisting of $9.6 million of exit costs and $2.4 million of asset impairment charges primarily related to property and equipment.

(3) During the three months ended March 30, 2014, the Company recorded special charges of $56.5 million, consisting of $41.0 million for the portion of a license payment attributed by the Company to the use of the related technology in periods prior to the date of the related license agreement, $10.6 million of exit costs and $4.9 million of asset impairment charges primarily related to property and equipment. The Company also recorded incremental tax charges of $14.7 million consisting of valuation allowances related to deferred tax assets for certain state tax credits and net operating loss carryforwards.

(4) During the three months ended March 31, 2013, the Company recorded $14.3 million of income tax benefits associated with adjustments to certain tax positions subject to an IRS examination and $5.0 million related to the retroactive reinstatement of the federal research tax credit.